Targeting respiratory complex I to prevent the Warburg effect.

Area of Science:

• Oncology
• Cancer Metabolism
• Mitochondrial Function

Background:

• The Warburg effect, a hallmark of cancer metabolism, involves a shift towards glycolysis.
• Cancer cells display significant metabolic plasticity, adapting their energy production pathways.
• Mitochondrial function, particularly respiratory complex I, is increasingly recognized for its role in tumor progression and adaptation.

Purpose of the Study:

• To revisit the definition of the Warburg effect in light of cancer cell metabolic plasticity.
• To discuss the critical role of mitochondrial respiratory complex I in cancer adaptation.
• To explore the potential of targeting complex I as a novel anticancer strategy.

Main Methods:

• Review of recent findings on cancer cell metabolism and mitochondrial function.
• Analysis of the role of respiratory complex I in metabolic and hypoxic adaptation.
• Discussion of pharmacological and genome editing approaches targeting complex I.

Main Results:

• Cancer cells can shift from glycolysis to oxidative metabolism during tumor progression.
• Mitochondrial respiratory complex I is essential for cancer cell adaptation to metabolic and hypoxic conditions.
• Complex I represents a viable target for anticancer therapies.

Conclusions:

• Targeting mitochondrial respiratory complex I is a promising adjuvant therapy for cancer.
• Pharmacological and genome editing strategies can be developed to inhibit complex I.
• Revisiting cancer metabolism highlights complex I as a critical vulnerability.